Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 27.39
+0.38 (1.41%)
At close: Jan 19, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 3.05 billion as of January 23, 2026. Its market cap has increased by 0.76% in one year.
Market Cap
3.05B
Enterprise Value
2.48B
Revenue
167.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.39
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 3.05B, a decrease of -24.88%. That is a compound annual growth rate of -8.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 3.05B | 16.53% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 3.49B |
| Guangdong VTR Bio-Tech | 3.42B |
| Cabio Biotech (Wuhan) | 3.39B |
| Suzhou Fushilai Pharmaceutical | 3.33B |
| Landfar Bio-medicine | 2.92B |
| Shanghai Universal Biotech | 2.80B |
| Jiangsu Sihuan Bioengineering | 2.80B |
| Shandong Sito Bio-technology | 2.77B |